CoChat

Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels

WONG, V. W.‐S., WONG, G. L.‐H., TSANG, S. W.‐C., HUI, A. Y., CHAN, A .W.‐H., CHOI, P. C.‐L., CHIM, A. M.‐L., CHU, S., CHAN, F. K.‐L., SUNG, J. J.‐Y., CHAN, H. L.‐Y. · 2009 · Alimentary Pharmacology & Therapeutics
Cited by 125

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: Background Non‐alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in affluent countries. Serum alanine aminotransferase (ALT) level is commonly performed to monitor NAFLD patients, but its clinical relevance is unclear. Aim To evaluate the metabolic and histological features of NAFLD patients with different ALT levels. Methods A total of 173 consecutive patients with biopsy‐proven NAFLD were studied. Patients with persistently normal ALT and those with abnormal ALT were compared. Results Patients with persistently normal ALT had lower steatosis grade than patients with abnormal ALT, but they had similar degree of lobular inflammation, ballooning and fibrosis. Among 19 patients with ALT below 0.5 times the upper limit of normal (ULN) at the time of liver biopsies, 8 (42%) and 3 (16%) had steatohepatitis and significant fibrosis respectively. The within‐patient coefficient of variance was similarly high in patients with simple steatosis and steatohepatitis (33.5). Age and glucose, but not ALT, were independent factors associated with significant fibrosis. Discussion Metabolic factors, but not ALT, are associated with histological severity. Patients with ALT < 0.5 × ULN may still have non‐alcoholic steatohepatitis (NASH) and significant fibrosis. Evaluation of NAFLD patients should be based on metabolic risk factors, but not ALT level.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2008.03896.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 125

Metadata

Authors
WONG, V. W. ‐., WONG, G. L. ‐., TSANG, S. W. ‐., HUI, A. Y., CHAN, A. W. ‐., CHOI, P. C. ‐., CHIM, A. M. ‐., CHU, S., CHAN, F. K. ‐., SUNG, J. J. ‐., & CHAN, H. L. ‐.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2009-01-08
Volume
29
Issue
4
Pages
387-396
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2036698572
Cited by
125
References
4
FWCI
4.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. https://app.cochat.ai/papers/10.1111/j.1365-2036.2008.03896.x
The paper
WONG, V. W. ‐., WONG, G. L. ‐., TSANG, S. W. ‐., HUI, A. Y., CHAN, A. W. ‐., CHOI, P. C. ‐., CHIM, A. M. ‐., CHU, S., CHAN, F. K. ‐., SUNG, J. J. ‐., & CHAN, H. L. ‐. (2009). Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2008.03896.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.